A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results